Since we did not analyze the transcriptome and chromatin binding patterns of CBX7 or c-MYC in meningioma cells with or without CBX7, we cannot exclude the possibility that c-MYC or CBX7 regulates other pathways to mediate the metabolic switch and inhibit cell proliferation. The gene discussed is MYC; the disease is meningioma.